Ignite Creation Date:
2025-12-25 @ 3:28 AM
Ignite Modification Date:
2026-05-23 @ 4:44 PM
Study NCT ID:
NCT02823405
Status:
COMPLETED
Last Update Posted:
2020-07-07
First Post:
2016-07-01
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
X4P-001 and Pembrolizumab in Patients With Advanced Melanoma
Sponsor:
X4 Pharmaceuticals
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
X4P-001-MELA
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None